Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the Clinic

Infinitopes England United Kingdom United States of America

Visionary sector leaders Dan Menichella and Jo Brewer, PhD join as Non-Executive DirectorsBringing strengths in strategy, immuno-oncology science execution from bench to approval, major partnerships and collaborations, and biotech scale upTo support the acceleration of proof-of-concept cancer vaccine, ITOP1, into Phase I/IIa clinical development, to prevent the recurrence of oesophageal cancersView original content:https://www.prnewswire.co.uk/news-releases/infinitopes-strengthens-board-with-two-biotech-leaders-to-advance-precision-immunotherapies-into-the-clinic-302406159.html

@ prnewswire.co.uk | CH0038389992 INFINITOPES